Related Experiment Video
Updated: Aug 29, 2026
Isolation of Cortical Microglia with Preserved Immunophenotype and Functionality From Murine Neonates
Published on: January 30, 2014
Microglial activation with atypical proinflammatory cytokine expression in a rat model of Parkinson's disease
Amaicha M Depino1, Chris Earl, Elke Kaczmarczyk
1Institute Leloir Foundation-CONICET-University of Buenos Aires, Avenue Patricias Argentinas 435, (1405) Buenos Aires, Argentina.
Abstract:
Microglial activation has been associated with the pathogenesis of Parkinson's disease (PD). Among the many components of this reaction, cytokines have been proposed as candidates to mediate neurodegenerative or neuroprotective effects. We investigated the interleukin-1 system and tumour necrosis factor-alpha mRNA and protein levels at different time intervals in the subacute intrastriatal 6-hydroxydopamine rat model of PD, in parallel with the inflammatory response. Immunohistochemistry showed that microglial cells were activated from days 6-30 postlesion in the substantia nigra pars compacta. This microglial activation was accompanied by an atypical proinflammatory cytokine production: Interleukin-1alpha and beta mRNAs were found to be elevated 30 days post-6-hydroxydopamine injection (2- and 16-fold, respectively), but no induction for interleukin-1alpha or beta at the protein level was detected by ELISA. As a control, a classical proinflammatory stimulus, namely endotoxin, was capable of inducing these cytokines at similar mRNA levels but also at the protein level. In addition, tumour necrosis factor-alpha mRNA was hardly or not detected in the substantia nigra at any time point studied. Our data point out a tight control of key proinflammatory cytokine production in our model of PD. This work supports the notion that chronic neuronal death per se does not induce secretion of these proinflammatory cytokines but that an additional stimulus is necessary to stimulate proinflammatory cytokine production. The production of proinflammatory cytokines from "primed" microglia may in turn modulate disease progression as has been recently proposed in a model of prion disease.
Insights
Parkinson's disease models show activated microglia but limited pro-inflammatory cytokine release. Chronic neuronal death alone doesn't trigger cytokine secretion, suggesting additional stimuli are needed for microglial activation in Parkinson's disease.
Area of Science:
- Neuroscience
- Immunology
- Pathology
Background:
- Microglial activation is implicated in Parkinson's disease (PD) pathogenesis.
- Cytokines are key mediators in neuroinflammation, potentially driving neurodegeneration or protection.
- The role of specific cytokines in PD models requires further elucidation.
Purpose of the Study:
- To investigate interleukin-1 (IL-1) system and tumor necrosis factor-alpha (TNF-α) mRNA and protein levels in a rat model of PD.
- To correlate cytokine expression with microglial activation and inflammatory responses in the substantia nigra.
- To determine if chronic neuronal death alone induces pro-inflammatory cytokine production.
Main Methods:
- Subacute intrastriatal 6-hydroxydopamine (6-OHDA) rat model of PD.
- Immunohistochemistry to assess microglial activation in the substantia nigra pars compacta.
- ELISA and mRNA analysis to quantify IL-1α, IL-1β, and TNF-α levels at various time points post-lesion.
- Endotoxin as a positive control for pro-inflammatory cytokine induction.
Main Results:
- Microglial activation observed from days 6-30 post-6-OHDA injection.
- Elevated IL-1α and IL-1β mRNA levels (2- and 16-fold) at 30 days post-lesion, but no corresponding protein induction detected by ELISA.
- TNF-α mRNA was minimally detected in the substantia nigra.
- Endotoxin induced both mRNA and protein for IL-1 cytokines, unlike the 6-OHDA model.
Conclusions:
- Parkinson's disease models exhibit tight control over pro-inflammatory cytokine production.
- Chronic neuronal death in PD pathogenesis does not inherently trigger significant pro-inflammatory cytokine secretion.
- An additional stimulus is necessary to activate cytokine production from primed microglia, potentially modulating disease progression.
